Wei Jiang, MD, PhD

Wei Jiang, MD, PhD

Contact Dr. Jiang

132 South 10th Street
Main Building, 285L
Philadelphia, PA 19107

(215) 503-5665

Most Recent Peer-reviewed Publications

  1. Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer
  2. The FDA-approved anthelmintic pyrvinium pamoate inhibits pancreatic cancer cells in nutrient-depleted conditions by targeting the mitochondria
  3. Erratum: Correction: Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer (eLife (2018) 7 PII: e69256)
  4. Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer
  5. Is the Use of Intraoperative Frozen Section During Pancreaticoduodenectomy Justified?
  6. Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcoma
  7. Genomic characterization of malignant progression in neoplastic pancreatic cysts
  8. Extra-articular synovial chondromatosis of the ankle: Unusual case with radiologic-pathologic correlation
  9. PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth
  10. Abemaciclib is effective against pancreatic cancer cells and synergizes with HuR and YAP1 inhibition
  11. Multiple tumor suppressors regulate a hif-dependent negative feedback loop via ISGF3 in human clear cell renal cancer
  12. Synchronous gastric and duodenal metastases from head and neck squamous cell carcinoma: A unique presentation of upper gastrointestinal bleeding
  13. Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer
  14. Elevated HuR in pancreas promotes a pancreatitis-like inflammatory microenvironment that facilitates tumor development
  15. Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis from the International Phase III ESPAC-3 Clinical Trial
  16. Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma
  17. Posttranscriptional regulation of PARG mRNA by HuR facilitates DNA repair and resistance to PARP inhibitors
  18. Posttranscriptional upregulation of IDH1 by HuR establishes a powerful survival phenotype in pancreatic cancer cells
  19. Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma
  20. Immunohistochemistry successfully uncovers intratumoral heterogeneity and widespread co-losses of chromatin regulators in clear cell renal cell carcinoma
  21. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells
  22. Recurrence and survival after resection of small intraductal papillary mucinous neoplasm-associated Carcinomas (≤ 20-mm invasive component) A multi-institutional analysis
  23. MUC1 promoter-driven DTA as a targeted therapeutic strategy against pancreatic cancer
  24. Retroperitoneal nodular fasciitis: A benign etiology on the differential diagnosis of malignant gastric outlet obstructi
  25. Diagnostic utility of TP53 and cytokeratin 7 immunohistochemistry in idiopathic inflammatory bowel disease-associated neoplasia